10/22/2024Everest Announces Positive Results of Chinese Subpopulation Data from ...

10/21/2024Europe's Share of Global Clinical Trials Shrinks as China Gains Ground...

10/21/2024USFDA Grants Fast Track Designation to Coherent Biopharma's CBP-1008

10/21/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

10/21/2024BeiGene's Secures 14th Indication in China for Tislelizumab

10/21/2024Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...

10/18/2024AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...

10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...

10/17/2024MSD Files NDA for WINREVAIR (sotatercept) in China

10/16/2024Hengrui Medicine Launches Phase 1/2 Trial for Nectin-4 ADC SHR-A2102 i...

10/16/2024Akeso Launches Phase 1/2 Trial of AK129 and AK117

10/16/2024GSK's Submits Priority Review Application for BCMA ADC in China

10/16/2024Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab

10/16/2024Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...

10/15/2024Dizal's Sunvozertinib Granted BTD in China for Treatment-Naive EGFR Ex...

10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...

10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...

10/10/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...

10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...

10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...

10/1/2024LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...

10/1/2024Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003

10/1/2024MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201

10/1/2024Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...

10/1/2024Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC

10/1/2024AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...

10/1/2024NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...

10/1/2024Asieris Pharma Reports Positive Phase III Results for Cervical HSIL Tr...

9/27/2024Innovent Submits Marketing Application for Antibody Drug IBI112 for Ps...

9/27/2024Junshi Announces EC Approval of Toripalimab

Page:9/11 Total number of articles:323: [First][<<] [7] [8] [9] [10] [11] [>>] [End]